Olodaterol Bridging Study in Asthma

Summary

The aim of the study is to establish the olodaterol dose in the ethanolic fixed dose combination (FDC) with BI 54903 which is equivalent in bronchodilator effect and systemic exposure to the 5 µg olodaterol reference dose in the aqueous inhalation solution (AIS).

Timeline

Start

2011-10

Primary completion

—

Completion

—

Drugs

Indications